公开(公告)号：EP3940000A1

公开(公告)日：2022-01-19

申请号：EP20770859.5

申请日：2020-03-13

申请人： Korea University Research and Business Foundation ,  Seoul National University R & DB Foundation

发明人： SEO, Hong Seog ,  LEE, Yong Jik ,  JEONG, Jae Min ,  LEE, Yun Sang ,  PARK, Ji Yong

IPC分类号： C08B37/00 ,  G01N33/58 ,  G01N33/60

摘要： A carrageenan derivative according to the present disclosure can quickly and easily detect and label the presence of inflammation-related macrophages and, particularly, can accurately and easily identify M1-type macrophages highly associated with early inflammation. In addition, the carrageenan derivative has advantages in that it can be produced easily, environmental pollution is minimized because a small amount of organic solvent is used, and initial cost is low.

公开(公告)号：EP3108901A1

公开(公告)日：2016-12-28

申请号：EP15752671.6

申请日：2015-02-17

申请人： Korea University Research and Business Foundation ,  Seoul National University R & DB Foundation

发明人： SEO, Hong Seog ,  KIM, Sungeun ,  KIM, Eung Ju ,  JEONG, Jae Min

IPC分类号： A61K51/04 ,  A61K49/06 ,  A61K51/02 ,  A61P9/10

CPC分类号： A61K51/081 ,  A61K51/04 ,  A61K51/044 ,  A61K51/048 ,  A61K51/0482 ,  A61K51/0491

摘要： The present disclosure relates to a composition for imaging atherosclerosis and a method for diagnosing atherosclerosis using the same. The composition for imaging atherosclerosis according to the present disclosure shows excellent atherosclerosis diagnosis accuracy, enables diagnosis of atherosclerosis even for a person with diseases of glucose metabolism such as diabetes and enables effective diagnosis even for atherosclerosis occurring in the brain and heart. In addition, manufacturing cost is low compared with the existing imaging composition for diagnosis of atherosclerosis. Therefore, atherosclerosis can be effectively diagnosed by using the same.

摘要翻译： 本发明涉及一种用于成像动脉粥样硬化的组合物和用于使用相同的诊断动脉粥样硬化的方法。 动脉粥样硬化gemäß成像本公开的组合物显示出优异的动脉粥样硬化的诊断精确度，动脉粥样硬化启用诊断即使对于葡萄糖代谢的疾病的人：如糖尿病和启用有效的诊断即使对于动脉粥样硬化在大脑和心脏发生的。 另外，制造成本低与动脉粥样硬化的诊断现有成像组合物相比。 因此，动脉粥样硬化可以通过有效地使用相同的诊断。

公开(公告)号：EP3909573A1

公开(公告)日：2021-11-17

申请号：EP20739100.4

申请日：2020-01-10

申请人： Korea University Research and Business Foundation

发明人： SEO, Hong Seog ,  LEE, Yong Jik ,  SONG, Jong-Suk ,  EOM, Young Sub

IPC分类号： A61K31/165 ,  A61K9/00 ,  A61P27/12 ,  A23L33/10

摘要： The present disclosure relates to a pharmaceutical composition for treating or preventing diabetic cataract, which contains midodrine or a pharmaceutically acceptable salt thereof as an active ingredient.